Secretory breast cancer in a boy: A case report with genetic analysis using next-generation sequencing and literature review

Medicine (Baltimore). 2023 Jul 7;102(27):e34192. doi: 10.1097/MD.0000000000034192.

Abstract

Rationale: Male secretory breast cancer is a rare, low-grade carcinoma, especially in boys. Due to its rarity, not much is known about this disease.

Patient concerns: A 5-year-old boy presented with a 1.4 cm painless mass in the right breast.

Diagnoses: Ultrasonography could not distinguish whether the breast tumor was benign or malignant. After a biopsy of the lumpectomy specimen, it was diagnosed to be secretory breast carcinoma.

Interventions: The patient underwent a modified radical mastectomy for his right breast. No postoperative chemotherapy or radiotherapy was performed. Next-generation sequencing of 211 cancer-related genes was detected, and the results revealed an ETV6-NTRK3 translocation and a PDGFRB c.2632A > G mutation. None of the most commonly altered molecules in male aggressive breast cancer (such as BRCA1-2, TP53, RAD51C, and RAD51D mutations) has been identified.

Outcomes: The patient was still free from local recurrence or metastases at 6-month follow-up.

Lessons: The genomic profile of male pediatric SCB is relatively simple, no other known driver genes have been found except for the ETV6-NTRK3 fusion. Our report will improve our understanding of secretory breast cancer.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Biomarkers, Tumor / genetics
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / pathology
  • Breast Neoplasms, Male* / genetics
  • Child
  • Child, Preschool
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Mastectomy
  • Oncogene Proteins, Fusion / genetics

Substances

  • Oncogene Proteins, Fusion
  • Biomarkers, Tumor

Supplementary concepts

  • Secretory breast carcinoma